1. Home
  2. VICI vs KVUE Comparison

VICI vs KVUE Comparison

Compare VICI & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VICI Properties Inc.

VICI

VICI Properties Inc.

HOLD

Current Price

$28.16

Market Cap

32.4B

Sector

Real Estate

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.32

Market Cap

33.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VICI
KVUE
Founded
2016
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Specialty Chemicals
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.4B
33.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
VICI
KVUE
Price
$28.16
$17.32
Analyst Decision
Buy
Buy
Analyst Count
15
12
Target Price
$34.67
$20.00
AVG Volume (30 Days)
13.6M
32.7M
Earning Date
02-19-2026
02-05-2026
Dividend Yield
6.40%
4.81%
EPS Growth
N/A
35.31
EPS
2.63
0.75
Revenue
$3,969,078,000.00
$15,006,000,000.00
Revenue This Year
$5.66
N/A
Revenue Next Year
$2.85
$2.81
P/E Ratio
$10.69
$23.07
Revenue Growth
4.31
N/A
52 Week Low
$27.56
$14.02
52 Week High
$34.03
$25.17

Technical Indicators

Market Signals
Indicator
VICI
KVUE
Relative Strength Index (RSI) 44.22 58.82
Support Level $27.56 $16.93
Resistance Level $28.40 $17.31
Average True Range (ATR) 0.37 0.21
MACD 0.10 -0.02
Stochastic Oscillator 47.62 67.26

Price Performance

Historical Comparison
VICI
KVUE

About VICI VICI Properties Inc.

VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: